Basel A.

Basel A. is a seasoned expert in bioinformatics and computational biology, currently serving as a Consultant for Kingdom Health and as Director of Computational Biology at Nucleome Therapeutics. With experience in leading teams to explore innovative disease treatments, Basel has held significant roles at Bionl.ai, Phi Science Institute, Genetics and Bioinformatics Association, and Sensyne Health. Previous academic positions include postdoctoral research at the University of Oxford and a research assistant role at Brunel University London. Basel holds multiple degrees, including PhDs from the University of Liverpool in Computational Biology and Bioinformatics, and a BSc in Computer Engineering from the University of Jordan.